BANK OF MONTREAL /CAN/ - DELMAR PHARMACEUTICALS INC ownership

DELMAR PHARMACEUTICALS INC's ticker is DMPI and the CUSIP is 247078207. A total of 9 filers reported holding DELMAR PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BANK OF MONTREAL /CAN/ ownership history of DELMAR PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2019$2,000
+100.0%
4,2620.0%0.00%
Q4 2018$1,000
-66.7%
4,2620.0%0.00%
Q3 2018$3,0000.0%4,2620.0%0.00%
Q2 2018$3,000
-25.0%
4,2620.0%0.00%
Q1 2018$4,000
-20.0%
4,2620.0%0.00%
Q4 2017$5,000
-28.6%
4,262
-50.0%
0.00%
Q3 2017$7,000
-65.0%
8,5240.0%0.00%
Q2 2017$20,000
-44.4%
8,5240.0%0.00%
Q1 2017$36,000
+5.9%
8,5240.0%0.00%
Q4 2016$34,000
-34.6%
8,5240.0%0.00%
Q3 2016$52,0008,5240.00%
Other shareholders
DELMAR PHARMACEUTICALS INC shareholders Q3 2018
NameSharesValueWeighting ↓
Virtu Financial LLC 54,411$38,0000.00%
TRUSTCORE FINANCIAL SERVICES, LLC 5,000$3,0000.00%
FRANKLIN RESOURCES INC 804,000$551,0000.00%
CREDIT SUISSE AG/ 13,000$9,0000.00%
BANK OF MONTREAL /CAN/ 4,262$3,0000.00%
Citadel Advisors 22,260$15,0000.00%
Raymond James Financial Services Advisors, Inc. 12,500$9,0000.00%
ROYAL BANK OF CANADA 500$00.00%
LADENBURG THALMANN FINANCIAL SERVICES INC. 42,375$40,0000.00%
UBS Group AG 9,646$7,0000.00%
View complete list of DELMAR PHARMACEUTICALS INC shareholders